Trial Profile
Novel Approach of Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Cancer metastases; Spinal stenosis
- Focus Therapeutic Use
- 13 Apr 2021 Planned End Date changed from 31 Jan 2022 to 30 Jun 2023.
- 13 Apr 2021 Planned primary completion date changed from 28 Feb 2021 to 31 May 2022.
- 10 Jan 2019 Planned End Date changed from 30 Dec 2021 to 31 Jan 2022.